Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
2.130
0.00 (0.00%)
At close: Aug 7, 2026, 4:00 PM EDT
2.121
-0.009 (-0.42%)
After-hours: Aug 7, 2026, 5:06 PM EDT

Lipocine Revenue

Lipocine had revenue of $190.10K in the quarter ending June 30, 2026, a decrease of -69.48%. This brings the company's revenue in the last twelve months to $1.57M, up 409.37% year-over-year. In the year 2025, Lipocine had annual revenue of $1.98M, down -82.35%.

Revenue (ttm)
$1.57M
Revenue Growth
+409.37%
P/S Ratio
11.19
Revenue / Employee
$112,104
Employees
14
Market Cap
17.56M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.98M-9.22M-82.35%
Dec 31, 202411.20M8.13M264.67%
Dec 31, 20233.07M2.57M514.16%
Dec 31, 2022500.00K--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019164.99K-263.04K-61.45%
Dec 31, 2018428.03K--
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 20127.71M--
Dec 31, 2011---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Celularity26.55M
Werewolf Therapeutics21.00M
Marker Therapeutics3.55M
Pluri1.08M
Cocrystal Pharma225.00K
Revenue Rankings